☰

Raymon Durso, M.D. - Publications

Affiliations: 
Neurology Boston University School of Medicine, Boston, MA 
Area:
Parkinson's disease
Tree Info Grants Similar researchers PubMed Report error

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sparrow D, DeMolles D, Dubaz O, Durso R, Rosner B. Design issues in crossover trials involving patients with Parkinson's disease. Frontiers in Neurology. 14: 1197281. PMID 37670777 DOI: 10.3389/fneur.2023.1197281  0.346
2018 McNamara P, Durso R. The dopamine system, Parkinson's disease and language function Current Opinion in Behavioral Sciences. 21: 1-5. DOI: 10.1016/J.Cobeha.2017.10.010  0.399
2016 Morgan J, Clark D, Tripodis Y, Halloran CS, Minsky A, Wildman WJ, Durso R, McNamara P. Impacts of religious semantic priming on an intertemporal discounting task: Response time effects and neural correlates. Neuropsychologia. PMID 27450269 DOI: 10.1016/J.Neuropsychologia.2016.07.020  0.388
2016 Smart K, Durso R, Morgan J, McNamara P. A potential case of remission of Parkinson's disease. Journal of Complementary & Integrative Medicine. PMID 27379905 DOI: 10.1515/Jcim-2016-0019  0.497
2016 Harris E, McNamara P, Durso R. Possible selves in patients with right- versus left-onset Parkinson's disease. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 1-18. PMID 27141970 DOI: 10.1080/13825585.2016.1178211  0.421
2015 Harris E, McNamara P, Durso R. Novelty seeking in patients with right- versus left-onset Parkinson disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 28: 11-6. PMID 25812126 DOI: 10.1097/Wnn.0000000000000047  0.486
2014 Ratner MH, Farb DH, Ozer J, Feldman RG, Durso R. Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides. Interdisciplinary Toxicology. 7: 123-33. PMID 26109889 DOI: 10.2478/Intox-2014-0017  0.629
2013 Harris E, McNamara P, Durso R. Apathy in patients with Parkinson disease as a function of side of onset. Journal of Geriatric Psychiatry and Neurology. 26: 95-104. PMID 23584852 DOI: 10.1177/0891988713481267  0.538
2012 Modak A, Durso R, Josephs E, Rosen D. A rapid non invasive L-DOPA-¹³C breath test for optimally suppressing extracerebral AADC enzyme activity - toward individualizing carbidopa therapy in Parkinson’s disease. Journal of Parkinson's Disease. 2: 349-56. PMID 23646099 DOI: 10.3233/Jpd-012132  0.463
2011 Butler PM, McNamara P, Ghofrani J, Durso R. Disease-associated differences in religious cognition in patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 33: 917-28. PMID 21656414 DOI: 10.1080/13803395.2011.575768  0.581
2011 Butler PM, McNamara P, Durso R. Side of onset in Parkinson's disease and alterations in religiosity: novel behavioral phenotypes. Behavioural Neurology. 24: 133-41. PMID 21606574 DOI: 10.3233/Ben-2011-0282  0.464
2010 McNamara P, Stavitsky K, Durso R, Harris E. The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates. Parkinson's Disease. 2010. PMID 20948889 DOI: 10.4061/2010/263083  0.448
2010 McNamara P, Holtgraves T, Durso R, Harris E. Social cognition of indirect speech: Evidence from Parkinson's Disease. Journal of Neurolinguistics. 23: 162. PMID 20161657 DOI: 10.1016/J.Jneuroling.2009.12.003  0.548
2010 Butler PM, McNamara P, Durso R. Deficits in the automatic activation of religious concepts in patients with Parkinson's disease. Journal of the International Neuropsychological Society : Jins. 16: 252-61. PMID 19958570 DOI: 10.1017/S1355617709991202  0.507
2010 Holtgraves T, McNamara P, Cappaert K, Durso R. Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease. Brain and Cognition. 72: 189-96. PMID 19751960 DOI: 10.1016/J.Bandc.2009.08.004  0.323
2010 McNamara P, Stavitsky K, Harris E, Szent-Imrey O, Durso R. Mood, side of motor symptom onset and pain complaints in Parkinson's disease. International Journal of Geriatric Psychiatry. 25: 519-24. PMID 19711336 DOI: 10.1002/Gps.2374  0.487
2008 Stavitsky K, McNamara P, Durso R, Harris E, Auerbach S, Cronin-Golomb A. Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 21: 143-9. PMID 18797256 DOI: 10.1097/Wnn.0B013E318185E698  0.485
2008 McNamara P, Durso R, Harris E. Alterations of the sense of self and personality in Parkinson's disease. International Journal of Geriatric Psychiatry. 23: 79-84. PMID 17562520 DOI: 10.1002/Gps.1845  0.475
2007 McNamara P, Durso R, Harris E. "Machiavellianism" and frontal dysfunction: evidence from Parkinson's disease. Cognitive Neuropsychiatry. 12: 285-300. PMID 17558639 DOI: 10.1080/13546800701202316  0.571
2006 McNamara P, Durso R, Brown A. Religiosity in patients with Parkinson's disease. Neuropsychiatric Disease and Treatment. 2: 341-8. PMID 19412480 DOI: 10.2147/Nedt.2006.2.3.341  0.584
2006 McNamara P, Durso R, Harris E. Life goals of patients with Parkinson's disease: A pilot study on correlations with mood and cognitive functions. Clinical Rehabilitation. 20: 818-26. PMID 17005505 DOI: 10.1177/0269215506070811  0.434
2006 McNamara P, Durso R. Neuropharmacological treatment of mental dysfunction in Parkinson's disease. Behavioural Neurology. 17: 43-51. PMID 16720959 DOI: 10.1155/2006/138263  0.534
2005 Wegelin J, McNamara P, Durso R, Brown A, McLaren D. Correlates of excessive daytime sleepiness in Parkinson's disease. Parkinsonism & Related Disorders. 11: 441-8. PMID 16154796 DOI: 10.1016/J.Parkreldis.2005.05.007  0.527
2003 McNamara P, Durso R, Brown A. Relation of "Sense Of Self" to executive function performance in Parkinson's disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 16: 139-48. PMID 14501535 DOI: 10.1097/00146965-200309000-00001  0.434
2003 McNamara P, Durso R. Pragmatic communication skills in patients with Parkinson's disease. Brain and Language. 84: 414-23. PMID 12662979 DOI: 10.1016/S0093-934X(02)00558-8  0.522
2000 Durso R, Evans JE, Josephs E, Szabo G, Evans B, Fernandez HH, Browne TR. Variable absorption of carbidopa affects both peripheral and central levodopa metabolism. Journal of Clinical Pharmacology. 40: 854-60. PMID 10934669 DOI: 10.1177/00912700022009585  0.34
1998 Fernandez HH, Durso R. Clozapine for dopaminergic-induced paraphilias in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 597-8. PMID 9613761 DOI: 10.1002/Mds.870130338  0.507
1997 Durso R, Evans JE, Josephs E, Szabo GK, Evans BA, Handler JS, Jennings D, Browne TR. Central levodopa metabolism in Parkinson's disease after administration of stable isotope-labeled levodopa. Annals of Neurology. 42: 300-4. PMID 9307250 DOI: 10.1002/Ana.410420305  0.413
1997 Durso R. Chapter 17 Biotransformation and excretion: Quantitative studies of tissue metabolism Pharmacochemistry Library. 26: 315-335. DOI: 10.1016/S0165-7208(97)80164-X  0.387
1996 McNamara P, Krueger M, O'Quin K, Clark J, Durso R. Grammaticality judgments and sentence comprehension in Parkinson's disease: a comparison with Broca's aphasia. The International Journal of Neuroscience. 86: 151-66. PMID 8828068 DOI: 10.3109/00207459608986706  0.549
1993 Durso R, Isaac K, Perry L, Saint-Hilaire M, Feldman RG. Age influences magnitude but not duration of response to levodopa. Journal of Neurology, Neurosurgery, and Psychiatry. 56: 65-8. PMID 8429325  0.586
1992 McNamara P, Obler LK, Au R, Durso R, Albert ML. Speech monitoring skills in Alzheimer's disease, Parkinson's disease, and normal aging. Brain and Language. 42: 38-51. PMID 1547468 DOI: 10.1016/0093-934X(92)90055-J  0.393
1991 McNamara P, Durso R. Reversible pathologic jealousy (Othello syndrome) associated with amantadine. Journal of Geriatric Psychiatry and Neurology. 4: 157-9. PMID 1953968 DOI: 10.1177/089198879100400306  0.376
1990 Wolfe N, Katz DI, Albert ML, Almozlino A, Durso R, Smith MC, Volicer L. Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 53: 915-7. PMID 2266376 DOI: 10.1136/jnnp.53.10.915  0.35
1990 Saint-Hilaire M, Feldman RG, Durso R. Deprenyl for the treatment of early Parkinson's disease (IV) New England Journal of Medicine. 322: 1527.  0.579
1989 Durso R, Szabo G, Davoudi H, Feldman RG. Magnitude of response to levodopa in Parkinson disease as it relates to peripheral and central measurements of levodopa and associated metabolites. Clinical Neuropharmacology. 12: 384-92. PMID 2611763 DOI: 10.1097/00002826-198910000-00003  0.534
1988 Rainero I, Kaye JA, May C, Durso R, Katz DI, Albert ML, Wolfe N, Pinessi L, Friedland RP, Rapoport SI. Alpha-melanocyte-stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease. Archives of Neurology. 45: 1224-7. PMID 2847695 DOI: 10.1001/Archneur.1988.00520350062017  0.405
1982 Tamminga CA, Durso R, Fedio P, Chase TN. Vasopressin studies in Alzheimer's disease Psychopharmacology Bulletin. 18: 48-49.  0.301
1980 Lieberman AN, Kupersmith M, Neophytides A, Gopinathan G, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M. Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years. Advances in Biochemical Psychopharmacology. 23: 245-53. PMID 7395614  0.406
1980 Lieberman A, Kupersmith M, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Bear G, Goldstein M. Long-term efficacy of bromocriptine in Parkinson disease. Neurology. 30: 518-23. PMID 6768003  0.357
1979 Lieberman A, Kupersmith M, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Tartaro T. Bromocriptine mesylate in Parkinson's disease. New York State Journal of Medicine. 79: 1689-92. PMID 290866  0.435
1979 Lieberman A, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Tartaro T. Huntington's disease. New York State Journal of Medicine. 79: 1188-90. PMID 156887  0.332
1979 Lieberman A, Neophytides A, Kupersmith M, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M. Treatment of Parkinson's disease with dopamine agonists: a review. The American Journal of the Medical Sciences. 278: 65-76. PMID 39452  0.371
Show low-probability matches.